Brazil vs Oman: Statin use vs. average non-HDL cholesterol levels
Brazil
3.4
in 2018
Oman
3.4
in 2018
Brazil rank
75th
Oman rank
75th
Statin use vs. average non-HDL cholesterol levels over time
- Brazil
- Oman
How they compare
Brazil currently reports 3.4 against 3.4 in Oman, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Brazil ahead.
Brazil ranks 75th and Oman ranks 75th of 191 countries.
Across the 4 decades both report, Brazil averaged higher in 1 and Oman in 3.
Head to head by decade
| Decade | Brazil | Oman | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.68 | 3.48 | 0.2 | Brazil |
| 1990s | 3.7 | 3.77 | 0.07 | Oman |
| 2000s | 3.67 | 3.74 | 0.07 | Oman |
| 2010s | 3.5 | 3.53 | 0.0333 | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Brazil or Oman?
- Brazil, at 3.4 against 3.4 in Oman as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Brazil and Oman?
- 0, with Brazil ahead.
- How many years of comparable data are there for Brazil and Oman?
- 39 years are reported by both, from 1980 to 2018.
- How do Brazil and Oman rank globally for statin use vs. average non-hdl cholesterol levels?
- Brazil ranks 75th and Oman ranks 75th of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.